Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Yeungnam Med Sci > Volume 16(2); 1999 > Article
Review Recent Advances in the Drug Therapy of Osteoporosis.
Hyoung Woo Lee
Journal of Yeungnam Medical Science 1999;16(2):155-168
DOI: https://doi.org/10.12701/yujm.1999.16.2.155
Published online: December 31, 1999
Department of Internal Medicine College of Medicine, Yeungnam University Taegu, Korea.
prev next
  • 1,671 Views
  • 1 Download
  • 0 Crossref
  • 0 Scopus

Osteoporosis is one of the most important public health problems facing the aging population. Drug therapy for osteoporosis can be divided operationally into two main categories: drugs that inhibit bone resorption, and thus reduce bone turnover, and those that stimulate bone formation, exerting an anabolic effect. Antiresorptive agents such as estrogens, calcitonin, and bisphosphonates are most effective in the prevention of osteoporosis. Formation-stimulating agents such as sodium fluoride or monofluorophosphate, parathyroid hormone fragments, and anabolic steroids are of potential value in the treatment of established osteoporosis, where bone mass s already low and benefit from antiresorptive drug is likelyto be small. Recently, raloxifene, a selective estrogen receptor modulator, has become available in various countries for clinical use in the treatment of involutional osteoporsis . This paper will review the use of these drugs in postmenopausal woman.

Related articles

JYMS : Journal of Yeungnam Medical Science
TOP